Electrophoresis Equipment & Supplies Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (DNA Electrophoresis, RNA Electrophoresis, and Protein Electrophoresis), By Product (Gel Electrophoresis Systems, Capillary Electrophoresis Systems, Electrophoresis Supplies & Accessories), By End User (Biotechnology and Pharmaceutical Industries, Diagnostic Centers, Academic & Research Institutes, Others), By Region and Competition, 2020-2030F

Market Overview

The Global Electrophoresis Equipment & Supplies Market was valued at USD 2.26 billion in 2024 and is expected to reach USD 2.98 billion by 2030 with a CAGR of 4.72% during the forecast period. The global market for Electrophoresis Equipment & Supplies is experiencing significant growth, driven by the increasing rates of cancer, genetic disorders, and infectious diseases. For instance, according to World Cancer Research Fund, around 18,094,716 million cancer cases were diagnosed in 2020 around the globe which is also increasing the demand of electrophoresis equipment & supplies for clinical diagnosis.

Additionally, rising funding for research activity in the fields of proteomics and genomics along with an increase in industry-academic research institute collaborations is expected to spur the growth of global electrophoresis equipment & supplies market. Research initiatives involving proteins and genes are becoming more prevalent, and there is an increasing need for novel medications and treatments.  Besides, a growing emphasis on next-generation sequencing (NGS) and associated research activities is further contributing to the growth of global electrophoresis equipment & supplies market.  The National Comprehensive Cancer Network (NCCN) recommends using NGS for a variety of tumor types, including non-small cell lung, breast, colon, ovarian, and pancreatic cancers, which account for many occurrences in the United States due to which rise in the demand for electrophoresis equipment & supplies market is growing rapidly.

Key Market Drivers

Surge in Public Funding for Life Sciences Research

Governments worldwide, particularly in the United States, are significantly increasing funding for life sciences research—with electrophoresis as a foundational laboratory technique in molecular biology and diagnostics. For example, U.S. federal spending on biomedical research through the NIH exceeded $41 billion in 2022, reflecting sustained governmental commitment to genomic and proteomic innovation. In the European Union, public research funding continues to grow under initiatives such as Horizon Europe and national strategies that aim for 3% of GDP to be dedicated to research and innovation by 2030.

This influx of governmental R&D support translates directly into increased procurement of electrophoresis systems and supplies—from gel tanks and power supplies to reagents like agarose and polyacrylamide gels. Public universities, government-funded laboratories, national genome centers, and public health institutes routinely deploy electrophoresis equipment to support research on genetic diseases, biomarker discovery, vaccine development, and quality control in biopharmaceutical manufacturing. With governments viewing biotechnology as strategic economic and health security infrastructure, electrophoresis instruments receive priority budget allocations within larger capital equipment investments.

The widespread funding also enables smaller academic and regional labs to upgrade older systems or adopt automated and advanced electrophoresis platforms. Not only does this increase unit sales, but it also creates recurring demand for consumables (e.g. buffers, molecular markers, stains), driving market expansion in both equipment and supply components.

Rising Demand for Precision Medicine and Biopharmaceutical Quality

Electrophoresis remains a cornerstone analytical technique for precision medicine, biopharmaceutical development, diagnostics, and proteomic/genomic research. As chronic diseases and genetic disorders rise globally, the need for accurate molecular separation and profile identification intensifies. According to WHO data, chronic conditions accounted for about 71% of global deaths in 2019—heightening demand for high-resolution analytical tools like electrophoresis to detect disease biomarkers, evaluate therapeutic targets, and monitor treatment responses.

Governments are channeling investments into developing biologics—including vaccines, therapeutic proteins, and gene therapies—which rely heavily on electrophoresis for purity testing, protein expression analysis, and quality assurance. National regulatory frameworks (e.g. FDA in the U.S., EMA in Europe) require electrophoretic validation during drug approval to ensure batch consistency and impurity profiling. Electrophoresis’s role in these compliance workflows makes it critical equipment for public and private biopharma laboratories.

A direct result of these developments: electrophoresis equipment and supplies are increasingly mandated in government-supported drug-development pipelines, public health labs, and regulatory testing centers. As governments tighten regulation on biologic safety and efficacy, electrophoresis technology becomes an indispensable instrumentation component across R&D and manufacturing workflows.

Download Free Sample Report

Key Market Challenges

Supply Chain Volatility and Critical Reagents Shortages

One significant challenge facing the electrophoresis market is volatile supply chains, especially for essential consumables such as agarose and polyacrylamide gels. Agarose—derived primarily from seaweed—is subject to seasonal harvest variability. In 2023, ocean-warming events linked to El Niño reduced seaweed yields by approximately 18% in producing regions, leading to a 27% price hike in agarose year-on-year.

Equally concerning is the shortage of semiconductor components used in modern electrophoresis systems (e.g. microcontrollers, UV sensors, electrode assemblies). Lead times for these parts extended from 12 weeks in 2021 to 34 weeks in 2023, seriously delaying manufacturing cycles. In fact, 42% of electrophoresis system makers reported production delays due to component scarcity, with some forced to cut output by up to 20%.

Government-funded labs are not shielded from these issues—frequent reagent stockouts and price spikes impact funded projects and clinical research timelines. For publicly funded initiatives, budget overruns due to price volatility can delay critical timelines in genomics or vaccine research. The dependence on single-source suppliers and geopolitical disruptions magnify risk; for example, platinum electrode shipments were disrupted by a fire at a major Japanese plant, halting nearly 40% of global supply for weeks.

Regulatory Complexity and High-Cost Barrier

Another challenge derives from the stringent regulatory environments governing electrophoresis equipment, particularly as medical diagnostic devices. In the United States, devices must pass through the FDA’s 510(k) pre‑market notification pathway, requiring robust validation data and GMP compliance—adding lengthy review cycles for new models.

In Europe, the implementation of the In Vitro Diagnostic Regulation (IVDR, effective 2022) imposes even stricter clinical evidence requirements on diagnostic tools, including electrophoresis-based assays. Manufacturers now need detailed performance data and possibly clinical trials to secure approval, increasing development costs and delaying market entry.

These regulatory burdens drive up costs for equipment development and conformant manufacturing, which in turn elevates prices for end users. Laboratories funded by governments—especially in low‑ and middle‑income regions—often face budget constraints that limit adoption of high‑cost electrophoresis platforms. Furthermore, operating advanced systems typically requires trained technicians; limited human capital in specialized roles can further restrict adoption and operational efficiency across government-funded institutions.

Key Market Trends

Automation and Miniaturization with Microfluidics & Capillary Systems

Electrophoresis technology is rapidly evolving toward automated, compact platforms, enabling higher throughput with less manual intervention. Innovations—such as capillary electrophoresis, microfluidic lab‑on‑a‑chip formats, and fully automated gel processors—are being widely invested in by public research labs and government-supported clinical centers. These trends align with national agendas supporting modernization of lab infrastructure under bio‑preparedness and precision medicine initiatives.

Capillary and microfluidic systems consume fewer reagents, save time, and reduce error rates compared to traditional gel electrophoresis, making them particularly attractive in government-funded genomics and proteomics programs. These devices are increasingly integrated with digital imaging and laboratory information systems (LIMS), enabling real-time visualization, autosave features, and cross‑departmental data sharing. Governments funding multi‑centre disease surveillance and genomic mapping projects gain significant operational advantage with these automated systems, allowing standardized, traceable workflows consistent with audit and regulatory needs. Importantly, many national lab modernization grants explicitly prioritize acquisition of such next‑generation platforms—boosting growth of automated and miniaturized electrophoresis segments.

Integration with Digital Analytics & Data‑Driven Platforms

A growing trend is the integration of electrophoresis systems with high‑resolution imaging, cloud connectivity, AI‑enabled analysis, and digital documentation tools. Modern electrophoresis workflows are increasingly linked to digital platforms that support quantification of bands, pattern comparisons, anomaly detection, and seamless exporting of results into databases or regulatory archives. This is particularly valuable in government healthcare and public research labs, where data traceability, standardization, and auditability are essential.

Governments are encouraging digital transformation in laboratories through funding programs tied to national digital health and research-data infrastructures. As a result, electrophoresis equipment featuring integrated digital imaging and analytics capabilities is replacing older, manual systems in many publicly funded facilities. These digital platforms reduce human error, enhance reproducibility, and streamline compliance with reporting standards.

Such integrated systems are especially important in multi-site public health initiatives, for example pathogen surveillance or biobank operations, helping ensure consistency across sites through automated data capture and standardized workflows. The trend toward smart electrophoresis platforms is thus accelerating, and governmental support for lab digitization is fueling widespread adoption.

Segmental Insights

Type Insights

Based on Type, Protein Electrophoresis holds the largest market share in the global electrophoresis equipment and supplies market. This dominance is primarily attributed to its widespread use in clinical diagnostics, biomedical research, and biotechnology applications. Protein electrophoresis plays a critical role in the identification and analysis of various proteins, including serum proteins, which are vital for diagnosing diseases such as multiple myeloma, liver disorders, and immune system dysfunctions. Clinical laboratories extensively use protein electrophoresis for routine testing, and hospitals increasingly rely on it for accurate and early disease detection. Its established utility in separating proteins based on size and charge makes it an indispensable tool for research institutions and pharmaceutical companies conducting protein analysis, biomarker discovery, and drug development.

Furthermore, advancements in automated electrophoresis systems and innovations in gel and capillary-based techniques have increased efficiency, accuracy, and throughput—factors that appeal to both large-scale research facilities and diagnostic laboratories. The accessibility of user-friendly systems and reagents tailored for protein analysis has also supported its growing use. In essence, the strong presence of protein-based disease diagnostics, coupled with rising investments in proteomics research, has enabled protein electrophoresis to maintain its lead over other types such as DNA and RNA electrophoresis. As a result, it continues to represent the largest share of the market by type.

Download Free Sample Report

Regional Insights

Based on the region, North America holds the largest market share in the Electrophoresis Equipment & Supplies Market, driven by its advanced research infrastructure, strong presence of life sciences companies, and continuous investments in biotechnology and clinical diagnostics. In the United States and Canada, there exists a well-developed ecosystem for biomedical research, pharmaceutical innovation, and academic institutions, all of which actively utilize electrophoresis technologies. The region is home to several globally recognized research centers and universities, which are consistently involved in cutting-edge genomic and proteomic studies. These institutions often require electrophoresis systems for protein separation, DNA analysis, and other molecular biology applications, thereby sustaining a steady demand for such equipment.

Furthermore, North America benefits from a high concentration of key industry players involved in manufacturing and distributing electrophoresis systems and related supplies. These companies, many headquartered in the U.S., continuously invest in research and development, ensuring regular innovation and faster adoption of advanced electrophoresis techniques across laboratories and hospitals. Additionally, the regulatory environment in North America supports the rapid approval and integration of new technologies in clinical and research settings. Government bodies such as the National Institutes of Health (NIH) and Canadian Institutes of Health Research (CIHR) frequently allocate funding to molecular diagnostics, life sciences research, and personalized medicine—sectors where electrophoresis is a core analytical technique. This consistent financial support fosters a favorable environment for the growth and maintenance of the electrophoresis market.

Recent Developments

• In January 2025, Bio-Rad Laboratories launched an automated electrophoresis platform with real-time AI-driven data analysis, improving efficiency in clinical diagnostics and genomic research.
• In March 2024, Thermo Fisher Scientific partnered with a leading biotech firm to develop high-speed capillary electrophoresis systems, enhancing protein characterization and biomolecular separation.

Key Market Players

• Agilent Technologies, Inc.
• Bio-Rad Laboratories Inc.
• Helena Laboratories Corporation
• Hoefer Inc.
• Lonza Group Ltd.
• Merck KGaA
• PerkinElmer Inc.
• SCIEX
• SERVA Electrophoresis GmbH
• Thermo Fischer Scientific Inc.

Report Scope:

In this report, the Global Electrophoresis Equipment & Supplies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Electrophoresis Equipment & Supplies Market, By Type:

o   DNA Electrophoresis

o   RNA Electrophoresis

o   Protein Electrophoresis

• Electrophoresis Equipment & Supplies Market, By Product:

o   Gel Electrophoresis Systems

o   Capillary Electrophoresis Systems

o   Electrophoresis Supplies & Accessories

• Electrophoresis Equipment & Supplies Market, By End User:

o   Biotechnology and Pharmaceutical Industries

o   Diagnostic Centres

o   Academic & Research Institutes

o   Others

• Electrophoresis Equipment & Supplies Market, By Region:

o   North America

§  United States

§  Mexico

§  Canada

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Japan

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Electrophoresis Equipment & Supplies Market.

Available Customizations:

Global Electrophoresis Equipment & Supplies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Electrophoresis Equipment & Supplies Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]